Fig. 2: Participant factors influencing baseline microbiome alpha diversity. | npj Breast Cancer

Fig. 2: Participant factors influencing baseline microbiome alpha diversity.

From: Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancer

Fig. 2

A Baseline alpha diversity composite of HER2- and HER2+ participants. Trajectories of (B) diarrhea symptoms and (C) nausea/vomiting symptoms of HER2 negative and positive participants. D Baseline alpha diversity composite of adjuvant and neoadjuvant participants. Trajectories of (E) diarrhea symptoms and (F) nausea/vomiting symptoms of adjuvant and neoadjuvant participants. Baseline alpha diversity composite compared via independent sample t-tests. Trajectory results shown are mean ± standard error from linear mixed-effects models. *p < 0.05.

Back to article page